CD163 and neoplasm: In patients with primary breast cancer, significant associations have been made for high densities of CD163+ immune cells and higher tumor grade, larger tumor size, lymph node positivity, Ki67-positivity, hormone receptor negativity and/or triple negative/basal like subtypes [7–12].